Last Updated : Monday, March 23, 2020 15:18:31

GLENMARK PHARMA gets USFDA nod to market for oral diabetic medicine

MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceutical products manufacturing company Glenmark Pharmaceuticals Ltd said of having got tentative approval from USFDA (US Food and Drugs Administration) to sell and market treatment to cure diabetic in form of oral diabetic medicine – Dapagliflozin Tablets, in dosage value of 5 mg (milligram) and 10 mg.

For LONG READ, please click :

In case, if the reader / viewer / visitor wishes to VERIFY the above narrated news-report, please CLICK here.


FacebookGoogle+LinkedinTwitterYouTube, Blogspot, Telegram, Instagram 


Do NOT follow this link or you will be banned from the site!